Rampant bird flu has torn across America’s livestock, sickened farm workers and resulted in the culling of millions of birds ...

A vaccine under development at the University at Buffalo has demonstrated complete protection in mice against a deadly ...

A nanoparticle-based vaccine candidate for H5N1 avian influenza achieved 100% protection in preclinical trials, offering hope ...

The recent success of an experimental bird flu vaccine in trials marks a significant step forward in the fight against avian influenza. Researchers from the University of Buffalo have demonstrated ...

A vaccine under development at the University at Buffalo has demonstrated complete protection in mice against a deadly ...

Recombinant proteins are important components for a wide range of applications, from therapeutic antibodies and vaccines to diagnostics and enzymes. Microbiosci is committed to advancing the science ...

Then, they add adjuvants, which are ingredients used to ramp up vaccine strength. The result is what’s known as a “recombinant protein vaccine.” It’s made without live or dead versions of ...

The adjuvants are mixed into the phospholipid layer. The vaccine is what's known as a recombinant protein vaccine. Unlike currently approved vaccines, which use live or dead versions of H5N1 ...